May 14, 2002 Dear Healthcare Professional, We would like to call to your attention a situation involving counterfeit labeling of Combivir� (lamivudine plus zidovudine) Tablets. GlaxoSmithKline has received four reports - Lamivudine zidovudine - Document - PDFSEARCH.IO

First Page	Meta Content
	May 14, 2002 Dear Healthcare Professional, We would like to call to your attention a situation involving counterfeit labeling of Combivir� (lamivudine plus zidovudine) Tablets. GlaxoSmithKline has received four reports Add to Reading List Open Document File Size: 16,84 KB Share Result on Facebook Company GlaxoSmithKline / / IndustryTerm healthcare professionals / / MedicalCondition HIV infection / hypersensitivity / injuries / hypotension / / Organization U.S. Food and Drug Administration / / / Position pharmacist / / Product Combivir / zidovudine / Trizivir / lamivudine / abacavir sulfate / Ziagen / / URL www.gsk.com / / SocialTag Fixed dose combination Dosage forms Cyclopropanes Organofluorides Abacavir Purines Lamivudine Zidovudine GlaxoSmithKline Pharmacology

May 14, 2002 Dear Healthcare Professional, We would like to call to your attention a situation involving counterfeit labeling of Combivir� (lamivudine plus zidovudine) Tablets. GlaxoSmithKline has received four reportsAdd to Reading List